Q1 2020 Earnings Call
[music].
[music].
[music].
Maybe the gentleman today's conference is scheduled to begin shortly please continue to standby. Thank you for adaptation.
[music].
Ladies and gentlemen, thank you for standing by and look into that Fabulous for health care incorporated first quarter 2020 earnings conference call. At this time of participants I know if and only mode.
The the speaker presentation that it'd be a question and answer session.
Ask a question during the session you and you have to cut star one on your telephone he's device that pays confidence as being recorded.
If you acquire any feathers and she's got stars Yeah, <unk> instead speaker today, Kevin <unk> General Counsel to go ahead.
Thank you in good evening.
I'm, Kevin Dell Corporate Counsel court tabby the rock the health care.
The company intends to a bell south of the Safe Harbor provisions of the private security litigation reform active 1995.
Certain statements made during this called will be forward looking statements within the meaning of that law.
These forward looking statements are subject to read uncertainties and other factors that could cause tabby the roster healthcare actual results to defer materially on those expressed or implied by the forward looking statements.
These risks and uncertainties include the developing nature of the market for technology enabled health care products and services.
Potential changes to laws and regulations that make impact our client.
For additional information on the rear facing tabby the roster health care.
Please refer to our filings with the F.B.C., including the risk factors section about 10 K. filed on more second 20 twin.
A recording of this call is accessible through a link on the Investor Relations page of our website and it will be available for 90 days.
I'm trying to call over to Doctor <unk>.
<unk>, chairman and founder of Kappeler us the healthcare.
<unk>.
Thank you Kevin.
Good evening and thank you for joining us for our first quarter 2020 earnings call.
With me today or talk to her worst one Alton co founder Chief marketing, a new business development officer.
And Mr. Bryan Adams, our Chief Financial Officer.
Along with Doctor, Kevin boasted are cheap sales officer.
<unk> and Kevin would both be available to respond to questions you have to we conclude our prepared remarks.
In our ongoing effort to improve our communications with investors.
This conference call and web cast is accompanied by a Powerpoint presentation available at the I.R. section of our website.
Your H.C. dot com.
And I wouldn't encourage you to download dislikes to follow along with our prepared remarks.
Given the disruptions beginning in early March from the Kobe 19 pandemic.
I am pleased to report first quarter 2020, total revenue of $72.8 million.
On gas adjusted EBITDA, a $4.8 million.
Both are near the high end of our guidance ranges.
Despite adjusted EBITDA being negatively impacted by additional costs related to <unk> 19.
Including one.
Higher I.T. expenses to enable.
Are 1300 member team.
Work remotely from home.
And to hire labor costs with the R. 100 team members working in our pace pharmacy fulfillment operations.
Before turning it over to Brian to expand on these numbers.
I want to discuss for key developments during the first quarter.
Then in subsequent weeks thereafter.
As reflected on slide three.
First.
Significant investments, we made in sales and marketing during 2019 are showing encouraging signs.
As of May 1st 2020 hour overall sales pipeline is 49% higher versus January 120, 20.
With the number of aggregate sales opportunities up.
Over 68%.
Importantly.
Our first quarter bookings.
Based one annualized recurring revenue.
More than two times higher.
Than any quarter during 2019.
We realized important pharmacy wins that how smart.
And also was a large pharmacy chain.
As well as a number of exciting wins with a motor health plan.
Well care.
Two of the top 10 largest health plans in the United States.
Second while we continue to significantly expand our client base with new wins.
We're also making progress with up sell efforts enabled by R.M. in a strategy.
Prescribe wellness, we are experiencing success of prescribed wellness 365, formerly known as we are <unk>.
P.W. 365 provides a virtual staff to help community pharmacists create new revenue streams.
For instance, enrolling patients in a medication synchronization program.
For this project we.
We were able to leverage Symphony is telepharmacy call centres around the country.
During Q1, P.W. 365 revenues increased threefold compared to a year ago.
Third I want to commend the efforts of our R. and D. organization, including our precision apartment therapy, R. and D. Institute led by our Chief Scientific Officer Doctor shock to John.
Earlier today.
Hosted a web in r. entitled important medications safety considerations for Kobe 19 treatment.
We also filed three different cobin 19 related studies with D.N.I.H. program.
For this project.
We were Ed wise risk score by simulating the effect of hiding cobin 19 related re purpose drugs such as hydroxy core Quinn core Quinn and Ram does a beer.
To the current medication regimen of seniors. These are people enrolled in our pace organization.
What we found was a significant increase in the mid wise <unk>, particularly with females.
Resulting in problematic heart this with me a risk among other things.
We are now expanding that study to a larger cohort of.
Oh really people from a large health plan.
To test an additional.
500000 patients in simulation.
As we mentioned in one of our press releases.
We signed an agreement to distribute the bio intelligence bio sticker.
And now to monitor the result in biological attributes.
Two are at risk pace members.
We were especially watching for key symptoms associated with Kobe 19.
In addition.
We were able to deliver cobin 19 test kits to our pace participants.
And for Americans more broadly through our prescribe within this network of more than 10000 pharmacies.
Fourth I wanted to acknowledge the vital role.
Pharmacists nationwide.
And our T.R.H.C. pharmacists are playing during the current pandemic.
We also very pleased about the future potential that exist as states expand the scope of pharmacy practice loss.
Highlighted by news at both the federal and state level.
For example on April 8th.
H.H.S. authorized to pharmacists to order and the Minister Kobe 19 testing its efforts to expand testing capabilities.
In Florida.
The Governor signed a bill H.B. 389 in March.
To expand patient access to healthcare, allowing pharmacist to test and treat a wide range of chronic conditions.
And following the passage of Ohio legislation in late 2019.
Formally recognised premises has health care providers.
The Ohio Pharmacists Association recently announced say new program with United Healthcare.
To pay community pharmacists to work with Medicaid patients to better manage chronic conditions.
In summary, it has been a rewarding quarter.
I'm extremely proud of our teams collected efforts.
Well now turn it over to Brian.
Brian.
<unk> I'm happy to report a good start to 2020 as promised her Q1 results reflect our new organizational structure comprised of our care Avention healthcare for paste segment, and our Medwise healthcare segments.
Or Medwise segment consists of our payer pharmacy and provider focus businesses.
Starting with slide for total revenue of $72.8 million increased 19% on a reported basis and 9% on inorganic basis.
Segment care bench in revenue increase to 15% all organic and Medwise revenue increased 29% on the reported basis, but declined 4% on an organic basis.
We didn't Medwise software subscriptions increased 185% on a reported basis and 7% on an organic basis, but medication 50 services declined by 7%.
As noted in our commentary on the slide the first quarter of 2019 benefited from two major factors first we sell record activity levels attributed to changes in M.T.M. program completion rates for C.M. ours is part of the C.M.S. Star rating system for 2019.
Second we pulled forward and material amount of revenue in 2019 in anticipation of bringing a large contract with C.B.S. help on line in the second half of 2019.
Shifting to profitability or gross margin, excluding depreciation and amortization continue to improve to 34% up 240 basis points versus a year ago.
Gap that loss of $14.4 million were 68 cents per diluted share compares with a net loss of $11 million supposed 54 cents per diluted share in the same period a year ago.
The increase lost is driven by 22% increase in operating expenses, excluding changes in fair value backwards <unk> related contingent consideration and higher interest expense.
Non gap adjusted deleted the P.S. of one set it down from 10 cents a year ago.
No and gap adjusted EBITDA of $4.8 million is down 16% versus a year ago, driven by higher operating investments to drive future growth as well as some additional expenses related to cope with 19, the cow highlighted earlier.
By segment, excluding corporate shared servitude care, eventually <unk> increased 11% to $11.7 million and medwise to increase the 72% to $2.8 million.
That are benefiting from staffing efficiency, even higher member engagement.
Moving the slide five consistent with our budget starting 2020, we expect cue to total revenue to be in the range of $76 million to $81 million, which represents organic growth of 026 percent.
With non gap adjusted EBITDA in the range of $7 million to $9 million.
There are three key factors to consider first we expect incremental medication fulfillment for our care Avention hates members, but would note are most recent pay census figures are showing negative trends for the first time in our history.
We didn't medwise for the same reasons. We noted earlier Q2 2020 represents a difficult comparison versus 2019, but we do expect the number of total clinical interventions to increase materially on a sequential basis versus Q1 with a similar sequential trajectory playing out in the second half of 2020.
Third while we were excited about the strength of our coupons bookings. These important wins are coming on line late in Q. too and will not be fully recognized until the second half of the year.
Which is in line with previously communicated expectations.
Moving on to slide number six we're maintaining our full year 2020 guidance with total revenue to be in the range of $332 million to $352 million.
Which represents growth of 17% to 24%.
<unk> in the range of 46 million to $52 million.
As we communicated during a cue for 2019 earnings call. Our 2020 revenue in adjusted EBITDA, It's more weighted towards the second half of the year as compared with prior years.
One key factor driving the seasonality if they're growing medwise pay your business, which represents the largest percentage of our overall pipeline with a number of large opportunities.
Well <unk> 19 pandemic did not have a significant impact on our first quarter 2020 revenue performance, it's too early to forecast the duration in magnitude of this pandemic and it's resulting impact on the remainder of 2020.
In addition to the pay fences headwinds described earlier there are additional factors that may negatively impact our sales in business development activities.
Specifically within our bed wide segment are three largest pharmacy trade shows during July have all been cancelled we hope to navigate around these ongoing challenges and I'm pleased with the strong efforts from our sales team today.
With that I will turn it back to the operator to open the call for the Q. and a session.
Operator.
Thank you.
Minded to ask a question you will need to touch Taiwan on your telephone.
Try your question has to pound key piece standby probably compatible.
And I first question cars.
<unk>.
Okay.
Yeah, a good good evening. This is Jerry dialing occur right. Thanks hurt their color and thanks for the question.
Brain curious I think you just made the comment within the the medwise to pay or visit specifically represents the largest percent sales pipeline I'm. Just curious if you could go into maybe a little bit more holler. There Oh, just on what specifically is rather than eating in that market right now and and how sustainable do you see that going forward.
I'm going to give that this one to Kevin boating I to keep.
<unk>.
Great, Thanks, Brian and and shared thanks for the question Yeah. The pipeline growth is we focused on Medicare that's a core business in enhancing MTM services with some medwise program, but the Medicare pipeline only represents about 25 per cent of current opportunities. So we have about.
Another 25% better and.
<unk> a combination of manage Medicaid some creative fee for service programs now that some of the states are doing carve outs of their their pharmacy benefit, but the remaining as in commercial and employer based plan specifically so as out <unk>, how employers look specifically at waist.
Reduce those costs with hospitalizations medwise is something that they're they're definitely interested and so we've gained a lot attraction in the pipeline relative to that.
Okay got it yeah. That's very helpful. And then maybe just one quick follow Oh, just relative to the guidance I think Brian last quarter. You mentioned there was like a 10 per cent bogey that was needed to go catch in terms of new business in order to to kind of comment lines.
Obviously, you have that really strong pipeline commentary and you maintain the outlet sounds like things are progressing nicely, but just curious if you could comment I wonder how you're kind of progressing on those French fries in light up the disruption from public 19 sure. Great question, we've closed about 20% to 25% the gap that we have.
At the the you render call rebate, Kevin a team have done the night job.
You know with that when we just talked about and the the pipeline continued to grow pretty nicely. So you know we've we've made the progress that we expected to me by that point.
Got it thanks very much.
Thank you.
And then next question constant David <unk> Your mind is how open.
Thank you. So if I can just quickly followed that last question. So if you look at the back half of the year because as you mentioned in your prepared remarks, it's a pretty steep route you know to hit your guidance in the back out so.
Is that this adjusting you have visibility and all but about suddenly or something yeah, 8% of the total year at this point and obviously that would be skewed to the last two quarters.
That's right David I would say that that is the k. now one caveat there is that that is.
That are are paid growth rate continue with.
<unk>, so we have seen a little bit of it blowing their but they are still in rolling members and while there might be a light in the near term you no longer term, we don't see that they're going to be impacted so you know that assumption does.
You know does have that we would be similar growth rate in the market for me earlier.
Right and actually my second question was on pay so you know thanks for the disclosure by the way that's very helpful to understand the business. So.
The solutions business I think your commentary said that you had a renewal maybe that the scope of services were reduced to which looks like it was about a million and a half dollars and a quarter.
In my understanding that right and so is that 6 million dollar had one for the year that has to be made up or my dad understanding that comment no.
Contract, it's about a million dollars the first quarter, it's not consistent throughout the remainder of the year you know in terms of 2019. So you know I don't expect that won't be that.
Level of impact throughout the year, but you know that that contract didn't change and so we are you know we're seeing now we would expect to see that Ram throughout the end at that hearing into next year.
So can you give us a sense of how much if I had one it is to your growth rate for the year.
So you know so again it was about a million dollars in the first quarter I would say you know it's safe to assume that you know just just for to make it easy I would say it somewhere between two and 3 million for me for the year.
Gotcha.
<unk>.
I think he says that the pace of well.
No pun intended here, but that rate I think you know ads same store sales growth. It must've been in March because I tend to January and February numbers were still high single digits.
<unk> when you said that you're seeing some slowing in that market.
And if so you know hotter, we actually do that I mean is that just all but just for option created by anybody doing anything as it relates to taking care of the elderly and changing that during this period or you know I'm just trying to get my arms around that state how we should factor that down I think.
I think that.
Current Joseph too 'cause she's really close to this but in general what's happening Hmm.
Based organization.
You know.
Pick application so to speak recruit and.
And then on the first of the month.
So for example, the person may they will they will.
Oh sure all those folks.
However.
So that could be you know whatever and then and then they have to subtract from that the debt.
And then you get the net.
And what we've seen as a little bit of.
Contraction on the admission, but we've seen a lot more of the debt.
I think it makes sense.
<unk>.
We have in the country.
Yeah, He's a Tory and co morbidity. So you know like in New York City, They really got hit based programs up there. So.
I think that's what you're what you're seeing her so would you want to.
Huh.
Having.
I mean at home and community based service.
Wonderful.
Term care.
Wanting to be.
<unk>.
Term.
Perhaps a little bit.
Yeah.
Long term, we believe that experience might really promote peace in a new way.
Yeah, just to add to that David one comment would be that may it's the first one where we really seen any.
Any contraction up until that point, even through April we haven't seen anything so really the first.
Got it and and does it wouldn't affect both solutions and product fulfill unleaded equally or what.
Okay.
<unk>.
All right I'll I'll get back in acute thanks very much. Thank you.
Thank you.
<unk> <unk>, especially in light you know I'm just hoping.
Hi, Thank you very much Brian you said something that was a mouthful that I didn't quite get record activity levels and key one due to changes in M.T.M. completion rates per C.M. ours, and then I lost yeah, but.
Can you go go back to that and then unpack it a bit yeah. So so in 2009 going into 2019.
The C.M. at Star ratings changed and they increase the benchmark that were required to be in order to.
Achieved certain start reading and so what that effectively did last year was.
Posted the number of C.M.R. that we needed to complete in order to hit the same star ratings that the plans were we're targeting.
So that created a a bit of a boost in as well in the first half of last year for two reasons. One we have more work to do and to many of the plan, we're a little nervous about being able to get to those to those measures and so they wanted to do it earlier on in the year. So we saw.
An increase in the overall number of clinical interventions that were completed in the first half a year.
Huh.
I think so and so that's why you're facing I'd I'd have cop for the first half 2020 is being.
Were there any change were there any changes to the requirements for delivering the the medication with use because of the cold at 19.
Over the past couple of months.
Yeah, we we have not seen any.
Okay.
Ah Okay on the the the benefit that we have now though and it was in our commentary was that people are are home. So there is an access.
Near where we're able to engage I think a little bit easier then.
We've been able to.
Okay and on the the pace trends so.
Can you comment on I hope that 19 incident rates within the pace centers that mikey, causing the the the pressure the numbers.
We don't know specifically, however, we do know that.
The exact same as trendy.
The states that are heaviest hit.
Like New York are the ones that we see they're getting attraction and others or Latin summer increase but.
Heavy state to what.
California.
Okay I think so much.
Oh, what's that are so I said Detroit, though.
And Detroit.
Okay. Thank you.
Thank you.
Next question comes a lucky again more with bad Yeah mine is horrible thing.
Hey, Thanks for the question, how better ones doing well.
I'm a pace sensitive issue.
Could you describe the magnitude of that is that going from you know then what your commentary almost made it sound like it was turning negative is that the case or is it just.
More muted growth rate.
You've seen historically for your clients.
I think that.
I think that it's.
Typically we see organic rose from our current pace programs anywhere from you know 102.
200 more patients.
That is the admissions last the death.
And this time.
Pretty flat.
So the trend.
It's coming down on the organic blow side temporarily.
Okay.
Exactly.
Yeah, the ones that are going to be susceptible to the to the virus.
Come on that to the debt.
Thanks.
Close.
Mmm.
No activity it's occurring.
Yeah.
Nurses went out to the home they got.
Goes around.
Yeah.
Okay, but but just to be clear on a year over year basis. This time.
Would still be up even if.
Month to month, you know from Oh, yeah.
Flat.
<unk>.
For the first quarter was above.
By like 200 people than it was.
Yeah.
So that.
Okay for the for the new pay your relationships that you announced or or you know maybe if you want to speech the pipeline that's easier I I guess I was curious from a product perspective.
Are these for traditional M.T.M. services are they more on the you know what enhanced M.T.
Kevin Kevin you're going to take that one yeah I'll take that it's it's a mix. We do have some programs that we're launching that are I'd, adding that midwife component to that traditional MTM program, we have programs, where they're using that wise and and unique situation. So.
Later this month or.
By the end of the second quarter, we plan to watch a program that is focused specifically I'm opioid patients who are taking opioid medications, there's quite a bit of interest in programs that also involves treatments for <unk> I hope it positive patients and so there's there's a combination.
End up like a couple of the bolt programs, though our leveraging our our strengths. So a couple of the large health plan programs that we mentioned are leveraging that my regional call centres the flexibility that they had without losing any momentum. They went from your brick and mortar call centres to remote call centres as well as the community pharmacies.
Particularly our 10000 independent set up adapted to help health plans provide new solutions and so those are focused on things like.
Improving gaps and care care gaps that might be related to Medicare part d. or even Medicare part c. measures. So both drug utilization measures as well as.
Part see the clinical measures. So a a combination of everything I think our ability to be flexible and an offer services through the different business units that we have it's been a real advantage for us.
And that I think okay, one of the thing that the the.
So this has been the first time in our history.
That is a public recognition.
Multi drug simultaneous interactions with guilty.
Cool.
<unk> that hit the news and everybody knows about them that people didn't so.
They do.
And and the study that we just did that we publish that we talked about.
Extended by N.I.H. is absolutely cute because what we did we took all these people.
Regiment that they had in place.
Condition, we added one.
Drugs incrementally that's all I.
<unk>.
So this is this a softening up the public market.
That there is a problem.
Real problem.
Somebody's got to come up with the balloon and we're the only ones that have that solution to this point. So we we believe that you're going to see some stuff coming out of us in the next.
Quarter to.
That's going to be taken advantage of that.
Okay, great. Thanks very much.
Thank you.
Next question <unk>, I'm, Sean doctorate I.V.C. capital markets.
Okay.
[noise] Gaffney thanks.
I guess I want to start so number your programs center on on being able to engage people in it it's been a common theme. We we've seen across some of the other companies that have recorded already got very engaging people now's, a a bit easier given all of the the sheltering in play that's happening I guess.
Are you experiencing that too and some of your programs that does that help out in in areas like M.T.M. or or the U.M.T.M. pilot.
Absolutely Yeah, we we have seen that already and it is generating some efficiencies on the topic inside as we worked through some of the the the different programs and some of the new programs that Kevin signed up. So we we are definitely seeing is that okay.
Okay, and then I guess on the on the bio and tell us on sticker you highlighted at the invest your day, you're now the the the principal distributor for that into the case program I'm curious how that contract worth it if if this unlock the new revenue stream for you all and then how meaningful that could be and and then from a capability standpoint.
How should we think about that.
Sitting in or or augmenting <unk>, what you're already doing.
Yeah.
I I.
I wouldn't think of it.
Exceptionally this boy, who just getting started with it.
See how it goes we we have high expectations.
Ended the year that it's going to be very attractive.
Yeah.
And also like.
Right now.
But we just got our first shipment of these things.
You know, we're just starting to test them.
And we've got the software set up and so I I don't Wanna over comments on that's because I'm not really sure.
How it's going to.
Work in in the real World.
Yeah, they're great Yeah, you sound a great about it.
It makes some sounds great about it but.
We'll see we'll probably know, we'll probably be able to give you a better answer and a couple of months yeah. Yeah. I agree I think we'll we'll be able to give you a better it's rubber or q. to call. You know at this point is that we just we just got these.
Starting to test them so.
From an economic model I wouldn't do that much in terms of contribution this year, we have an agreement with bio until.
Where we would.
It monthly fee.
Or thicker and for the connectivity that we would also charge the related to.
Providing as well so I think it's still pretty early on.
More probably the next couple of month.
Okay, great. Thanks again for the time.
Thank you.
Thank you.
My Dad's ask a question you will need to patch style one on your car.
The next question comes from Stephanie Davis, <unk> Caroline how open.
Hey, guys. Thank you for having me back and taking the question.
Welcome back.
Yeah. So you guys just touched on clothing, but why did the down a bit more into that that'd be the pace program.
So.
One of the big take away from all day that nursing home aren't looking so great.
Acknowledging that we're probably not seeing new pay center opening near term you have any views on what they can mean longer term for the broad of the program that it's still valid actively unknown.
I think.
<unk>.
Definitely is you're thinking for people to consider an alternative to long term care and then.
They had in the past.
So we definitely believe that interesting. It now people are living there <unk> patient their family members from nursing home and they need other alternative were.
Pace in that community there.
I didn't want to mention that.
<unk>.
<unk>.
Thing that too.
Some people are less likely to change plans.
Just helping.
I think there's is correct definitely I think that.
I I can't wait to see how the pace organization.
Taking this and marketing.
I think it's going to be I think you're absolutely right, it's going to be a real wonderful.
<unk>.
What else what it something to talk about right.
Yeah.
The school.
So yeah, I think I think you're right I think he's going to be really interesting.
Marketing I guess.
That's what I was thinking where does the the onus lie for this P.R. campaign, they get folks aware of the page program, but she was like that's what we need yep.
Yeah.
On page two or in nursing home.
Set of people, who will need nursing home level of care, regardless of whether they're on pace or not but for those who can still live at home I think it.
Alternative.
Yes.
Long term care now, but I think it'd be interesting to see how this thing plays out.
Oh 10, they have little Marty or pharmacy business.
All of this I think hearing a lot.
No other health pets players nothing more.
Enable consumer pharmacy solution.
Because because folks aren't able to their homes right. There's no consultation so how can be done virtually.
Could you walk us through any opportunities that you've seen come up at the result of all that.
Definitely I think you bring up it's a great point in Calif, and probably talk a little bit more about.
The role of apartments that today and tomorrow, but I can talk maybe for a moment about some of the things that we've already been doing as part of the the coded initiative, specifically with our our pharmacies, we've sent out over 2 million messages.
To help.
Educate people around around Kobe and also you know educate them on you know what is available out there pharmacies because it in so many people are afraid to go out and not sure what to do there's been a significant shifted to 90 days applied that these these pharmacies that are part of our network.
And you know, they're they're really seen as a an accent.
You know, we've got 10000 pharmacies in the prescribe well the network.
That can reach close to 300 million people in the U.S., we've got a pharmacy within five miles as a threat a million people. So we have a really interesting opportunity to play a pretty important goal and one of the first steps was bringing coded testing to those pharmacy. So we've got 3000 pharmacy.
Used that respond to do a thing that they were interested in delivering neat.
Locally and we've already sent out 3000.
Judys pharmacies as part of that program. So.
Maybe I'll, let Cal chime in on.
The future of pharmacy in that.
Well I think okay by thank you I think that there's a couple of things going on.
It is pharmacist started getting more.
Opportunities to help with chronic care patients says.
Did in a couple other states habit in in lined up to the pet also.
They need to do there if they need to document using snow mid codes and they need to also have tools performances prescribing.
We have both of those and Medwise, you know and Medwise and would prescribe on this combine the two software is we have are unbelievable I mean, they both work much they'll make codes they both have <unk>.
Mmm.
What is it very very few companies that.
Help these requirements as quickly.
Get that get that capability and we we know that that's going to happen that you you can't help people with chronic conditions now unless you've documented properly.
And that's not typically what fine this is too.
<unk>.
We have that embedded in the patient engagement center.
They can buy that from that option.
I'd like to just.
Met Kevin both and say one thing about that too because Kevin would you like to spend that just a little bit.
Yeah. It did a few things that come to mind relative to that question is although we've talked about you know patient engagement being a little bit easier because people are home, they're still tremendous value in the pairs working through us to have that communication come from the patience pharmacy, So Brian talked about the 2 million messages.
That have gone out to patients from the pharmacy. Many of those are on behalf of pairs, which is one of the revenue models, where where providing services for pairs passing that on to pharmacies and and they're using our technology to do it.
And be able to S. Cal sad for.
That patient engagement using the tools that we have those messages are going out and voice taxed.
They're going out on social media. So there's a lot of ways to engage patients and then word document in that and the prescribe on this platform in a in a way that's part of five so it can be transmitted back to physicians electronically back to the health plans electronically using the same model that we have an R.E.M.T.M. platform to hot.
Hi data and so it's it's a tremendous advantage so.
Terms of having patients to be remote and have access to Tallahassee technology, but then do it in in a matter that they are still interacting with somebody that they trust has been a huge advantage in one of the areas that has really helped us with a growth and the deals that we've closed in q. wine, we've continued that momentum in April and and.
Why we're optimistic about the rest of the years Wow.
And I think the listing. Thank you can I think the last thing stuff that we as launched if we go on that score.
<unk>.
Yeah.
Lunch now.
And in version one you have.
The other versions lined up.
Oh God.
So they're trying to stuff.
The local pharmacists so.
Also actively working down that path.
[noise] three more.
We're consumer focused and.
So.
I see a lot more that happening too.
I can see <unk>. Thank you can watch that request something.
Thank you, ladies and gentlemen, <unk> conference call. Thank you for participating you may not disconnect.
[music].
[music].
[music].
[music].